Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Share this:
March 31, 2016

Although Prostate-specific Antigen Screenings Now Result in Fewer Biopsies, Relative Risk of Complications has Increased

By Elizabeth Zimmermann

mss_522405While absolute rates of biopsy and post-biopsy complications have decreased following several benchmark prostate-specific antigen (PSA) screening publications, the relative risk for each patient continues to increase, according to a new study by Mayo Clinic researchers.

The study is the largest to examine the impact of PSA screening trials and revised PSA screening guidelines on rates of prostate biopsy and the first to examine their impact on post-biopsy complications. The results, which appear in European Urology, suggest a need to reduce the harm associated with biopsy.

Read the full news release.

###

Tags: Boris Gershman, Center for the Science of Health Care Delivery, Choosing Wisely, Findings, Jeffrey Karnes, OtumLabs, prostate cancer, prostate-specific antigen (PSA)

Contact Us · Privacy Policy